When was Sientra founded?

Sientra was founded in 2007 and raised its 1st funding round within a year of its incorporation.

Where is Sientra located?

Sientra is headquartered in Santa Barbara, United States. It is registered at Santa Barbara, California.

How many employees does Sientra have?

As of Mar 31, 2026, the latest employee count at Sientra is 108.

Is Sientra a funded company?

Sientra is a funded company, having raised a total of $150M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Apr 18, 2007.

When was the latest funding round of Sientra?

Sientra's latest funding was a $***** Post IPO round on Mar 11, 2020, with participation from 1 investor. Its primary sector is Women Health. In United States, the Women Health sector has seen $76.5M in funding in 2026 to date.

What is the annual revenue of Sientra?

Annual revenue of Sientra is between $50M and $100M as on Dec 31, 2022

Where does Sientra rank among its competitors?

Sientra ranks 3rd amongst 36 active competitors, of which 10 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Lattice Medical, which secured an undisclosed amount in Oct, 2025.

Who are the top competitors of Sientra?

Sientra's top competitors include Establishment Labs, GC Aesthetics and Healshape. Among them, Lattice Medical secured the most recent funding round in October, 2025.

Sientra - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Sientra develops and markets products focusing on the plastic surgery and aesthetics market. Its portfolio includes breast implants, breast tissue expanders, body contouring, facial implants, etc. The company went public in Oct 2014.

Website: sientra.com
Registered Address: Santa Barbara, California

Key Metrics

Founded Year

2007

Location

Santa Barbara, United States

Stage

Public

Total Funding

$150M in 3 rounds

Latest Funding Round

Post IPO, Mar 11, 2020, $*****

Investors

Deerfield & 5 more

Ranked

3^rd among 36 active competitors

Annual Revenue

$50M - $100M as on Dec 31, 2022

Employee Count

108 as on Mar 31, 2026

Similar Companies

Establishment Labs & 41 more

Exit Details

Public

View Sientra's full profile

Sientra is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SIENTRA, INC CIN: 205551000 , United States, Active	Dec 26, 999	-	259 (As on Dec 31, 2023)	-
Sientra, Inc. CIN: 20-5551000 , United States, Active	Aug 28, 2003	$50M - $100M (As on Dec 31, 2022)	319 (As on Dec 31, 2021)	-

Sientra got listed on Oct 29, 2014.

Click here to take a look at Sientra's IPO in detail

Sientra has raised a total funding of $150M over 3 rounds. Its first funding round was on Apr 18, 2007. Its latest funding round was a Post IPO round on Mar 11, 2020 for $*****. 1 investor participated in its latest round. Sientra has 6 institutional investors.

Here is the list of recent funding rounds of Sientra:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 11, 2020	6591935	Post IPO	8557660	2241498	5699990	1060039
Mar 28, 2012	7357732	Series C	3852147	3658619	3032119	Abingworth & 2 more
Apr 18, 2007	3893092	Series B	3124381	2458851	7641537	Orbimed & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Sientra's funding rounds and investors

Here are the details of Sientra's key team members:

Ron Menezes: CEO of Sientra.
Contact Info: 1 email address

Sientra's Board of Directors

Sientra's board has 7 active members. Robert Adelman, Hani Zeini, Joel Smith, Rishi Gupta, Michele Park, Nick Simon and Matthew Pigeon are independent board members.

Here is the list of Sientra's board of directors:

Name	Type	Representing	Status	Duration
Robert Adelman	Independent board member	-	Current	14y 1m
abucamj	Independent board member	-	Current	1y 5m
iosjfuq	Independent board member	-	Current	1y 4m
omrhbis	Independent board member	-	Current	2y 5m
oombrwg	Independent board member	-	Current	2y 2m
ss{{wxw	Independent board member	-	Current	7y 3m
zigegwt	Independent board member	-	Current	8y 3m

View details of Sientra's Founder profiles and Board Members

Sientra's employee count trend

Sientra has 108 employees as of Mar 26. Here is Sientra's employee count trend over the years:

Uncover Sientra's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sientra include Establishment Labs, GC Aesthetics and Healshape. Here is the list of Top 10 competitors of Sientra, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Establishment Labs 2010, Alajuela (Costa Rica), Public	Developer of silicone-filled breast and body shaping implants	$121M	Perceptive Advisors, Crown Predator Holdings ... & 7 others	70/100
2nd	GC Aesthetics 2007, Dublin (Ireland), Series E	Manufacturer of silicone breast implants for aesthetic and reconstructive surgery	$233M	Montreux Equity Partners, Barry’s Tea & 18 others	60/100
3rd	Sientra 2007, Santa Barbara (United States), Public	Products for plastic surgery/ aesthetics	$150M	Deerfield, Abingworth & 4 others	53/100
4th	Healshape 2020, Villeurbanne (France), Series A	Developer of products for breast reconstruction and augmentation	$12.8M	Demeter, Bpifrance & 4 others	51/100
5th	Lattice Medical 2017, Loos (France), Series B	Provider of 3D-printed technology for soft tissue reconstruction	$63.4M	Bpifrance, EIC Fund & 8 others	49/100
6th	AirXpanders 2006, Mountain View (United States), Public	Tissue exapnder for post mastectomy reconstructive surgery	-	Western Technology Investment, Vivo Capital ... & 8 others	45/100
7th	BellaSeno 2015, Leipzig (Germany), Unfunded	Developer of breast implants	-	-	43/100
8th	BioAesthetics 2015, New Orleans (United States), Series A	Developer of a tissue-engineered nipple-areolar complex	$7.4M	FemHealthVentures, Hemi Ventures & 16 others	42/100
9th	Tensive 2012, Milano (Italy), Series A	Prostheses for a natural breast reconstruction	$16.7M	CDP Venture Capital, UniCredit Start Lab & 3 others	41/100
10th	Ideal Implant 2006, Dallas (United States), Acquired	Medical device and biologics company innovating tissue and cell-based technologies	$17M	CB3 Holdings	39/100